CD155 loss enhances tumor suppression via combined host and tumor-intrinsic mechanisms.

Saved in:
Bibliographic Details
Title: CD155 loss enhances tumor suppression via combined host and tumor-intrinsic mechanisms.
Authors: Li XY; Immunology in Cancer and Infection Laboratory and., Das I; Immunology in Cancer and Infection Laboratory and., Lepletier A; Immunology in Cancer and Infection Laboratory and., Addala V; Medical Genomics, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia., Bald T; Immunology in Cancer and Infection Laboratory and., Stannard K; Immunology in Cancer and Infection Laboratory and., Barkauskas D; Immunology in Cancer and Infection Laboratory and., Liu J; Immunology in Cancer and Infection Laboratory and., Aguilera AR; Immunology in Cancer and Infection Laboratory and., Takeda K; Division of Cell Biology, Biomedical Research Center and Department of Biofunctional Microbiota, Graduate School of Medicine, Juntendo University, Tokyo, Japan., Braun M; Immunology in Cancer and Infection Laboratory and., Nakamura K; Immunology in Cancer and Infection Laboratory and., Jacquelin S; Gordon and Jessie Gilmour Leukaemia Research Laboratory, Immunology Department, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia., Lane SW; Gordon and Jessie Gilmour Leukaemia Research Laboratory, Immunology Department, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.; The Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia.; School of Medicine, The University of Queensland, Herston, Queensland, Australia., Teng MW; School of Medicine, The University of Queensland, Herston, Queensland, Australia.; Cancer Immunoregulation and Immunotherapy and., Dougall WC; Immunology in Cancer and Infection Laboratory and.; Immuno-oncology Discovery, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia., Smyth MJ; Immunology in Cancer and Infection Laboratory and.; School of Medicine, The University of Queensland, Herston, Queensland, Australia.
Source: The Journal of clinical investigation [J Clin Invest] 2018 Jun 01; Vol. 128 (6), pp. 2613-2625. Date of Electronic Publication: 2018 May 14.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Retracted Publication
Journal Info: Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 7802877 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1558-8238 (Electronic) Linking ISSN: 00219738 NLM ISO Abbreviation: J Clin Invest Subsets: MEDLINE
Database: MEDLINE Ultimate
Be the first to leave a comment!
You must be logged in first